ArticleClinical and experimental medicine2016

Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.

Shaohang Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.